What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
George V. Papatheodoridis mainly focuses on Internal medicine, Gastroenterology, Hepatitis B, Immunology and Hepatitis B virus.
His research in Internal medicine intersects with topics in Endocrinology and Pathology.
George V. Papatheodoridis studies Gastroenterology, namely Cirrhosis.
His biological study spans a wide range of topics, including Entecavir, Hepatology and Viral hepatitis.
His Lamivudine, HBsAg and Alpha interferon study in the realm of Immunology connects with subjects such as Chemistry.
His Hepatitis B virus research includes elements of Liver cancer, Viremia, Combination therapy and Viral load.
His most cited work include:
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (1745 citations)
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (981 citations)
- 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B (493 citations)
What are the main themes of his work throughout his whole career to date?
George V. Papatheodoridis focuses on Internal medicine, Gastroenterology, Immunology, Cirrhosis and Hepatitis B.
The Hepatocellular carcinoma research George V. Papatheodoridis does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Gastroenterology research incorporates elements of HBsAg, Lamivudine, Liver transplantation and Liver biopsy.
His studies in Liver biopsy integrate themes in fields like Steatohepatitis and Fatty liver.
The concepts of his Cirrhosis study are interwoven with issues in Hepatitis C, Hepatitis, Fibrosis, Ribavirin and Cohort.
George V. Papatheodoridis has researched Hepatitis B in several fields, including Viral hepatitis and Hepatitis B virus.
He most often published in these fields:
- Internal medicine (68.22%)
- Gastroenterology (49.36%)
- Immunology (20.97%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (68.22%)
- Gastroenterology (49.36%)
- Cirrhosis (19.70%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Chronic hepatitis and Hepatocellular carcinoma.
In the subject of general Internal medicine, his work in Hepatitis B is often linked to In patient, thereby combining diverse domains of study.
The various areas that George V. Papatheodoridis examines in his Gastroenterology study include Hazard ratio, Liver transplantation, Tenofovir and Fatty liver.
His Cirrhosis research integrates issues from Liver biopsy, Viral hepatitis, Liver disease, Etiology and Cohort.
His work in Chronic hepatitis addresses issues such as Hbeag negative, which are connected to fields such as Prospective cohort study.
His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Framingham Risk Score, Oncology and Colorectal surgery.
Between 2018 and 2021, his most popular works were:
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial (32 citations)
- Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals (23 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Cirrhosis, Gastroenterology, Hepatitis B and Hepatocellular carcinoma.
George V. Papatheodoridis has included themes like HBsAg, Hepatitis B virus and Chronic hepatitis in his Internal medicine study.
George V. Papatheodoridis works mostly in the field of Hepatitis B virus, limiting it down to concerns involving Hepatitis and, occasionally, Clinical trial, HBeAg and Clinical endpoint.
George V. Papatheodoridis interconnects Liver disease, Etiology, Cohort and Sofosbuvir in the investigation of issues within Cirrhosis.
As a part of the same scientific study, George V. Papatheodoridis usually deals with the Gastroenterology, concentrating on Entecavir and frequently concerns with Incidence.
His study looks at the relationship between Hepatocellular carcinoma and fields such as Framingham Risk Score, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
